The trial marks the first time the drug has been tested for treating nasal conditions. Nasal polyps are thought to affect ...

The following is a summary of "Real-world comparison of T2-biologics effectiveness in severe allergic asthma with nasal ...

Among patients with previous sinus surgery for chronic rhinosinusitis with nasal polyps, the number of past surgeries did not ...

Tezepelumab, a monoclonal antibody targeting thymic stromal lymphopoietin (TSLP), significantly reduces nasal polyps and congestion in patients with severe, uncontrolled chronic rhinosinusitis ...

Sanofi and Regeneron's fast-growing immunology drug Dupixent is on course for a third indication in Europe after being recommended for approval as a treatment for people with nasal polyps.

Chronic sinusitis with nasal polyps (CRSwNP) accounts for 20 to 33 percent of these cases. Even after surgical treatment, the recurrence rate of CRSwNP remains high, ranging from 20 to 60 percent ...